Marshall Wace North America’s Nurix Therapeutics NRIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-15,006
Closed -$524K 1484
2020
Q3
$524K Buy
+15,006
New +$524K ﹤0.01% 955